Aurogen will unleash Alzheimer’s drug

FORT COLLINS – Millions of people afflicted with two crippling diseases may find hope in a new drug treatment that has emerged from a Colorado State University biomedical laboratory.

And the founder of Aurogen Inc. and his newly hired CEO are working to bring the potentially life-saving product to market as soon as possible.

The illnesses that the new drug targets – Alzheimer’s disease and diabetic neuropathy – potentially afflict more than 32 million people in the United States alone, said Douglas Ishii, Aurogen’s founder and a professor of biomedical sciences at CSU.

Beyond the human toll, the effects of the two diseases…